Homepage
     About us
     Wholesale ph.
     Research
     Contact
 

Enkorten Multiple sclerosis Asthma Wholesale Pharmacy
 
 
News
Marketing authorisation of Enkorten in Bosnia and Herzegovina
Enkorten is registered in February 2010 in Bosnia and Herzegovina with a registration number 04-07.1-1655-1/09 issued from Drug Agency of Bosnia and Herzegovina.
WCN 2009
During the World Congress of Neurology (Bangkok, 24-30 October) Farmacija d.o.o. presented the results of phase III clinical study of Enkorten's efficacy in three different abstracts. Read more...
Safety Profile
Safety profile of Enkorten was presented during the III Congress of neurology nurses and techicians in Opatija from 22 to 25 of April 2009. Read more...
Clinical Phase III
In December 2008 a complex statistical analysis of clinical phase III results was completed. Read more...
Presentation of the clinical phase II
Clinical phase II results of efficacy of Enkorten were presented during the 12 EFNS Congress in Spain in 2008.  
Read more...
 
     News

 

World Congress of Neurology - Bangkok


During the World Congress of Neurology (Bangkok, 24-30 October) Farmacija d.o.o. presented the results of phase III clinical study of Enkorten's efficacy in three different abstracts.

Abstracts of presentations:

Mehmedica - Suljic - Bangkok 2009 (click to open)
Alajbegovic - Bankgok 2009 (click to open)
Merhemic - Bangkok 2009 (click to open)

 

 

 

 
 
   
Homepage About us Wholesale pharmacy Contact